• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】43009

【品名】6-bromo-3,3-dimethyl-1,2,3,4-tetrahydroquinoline

【CA登记号】

【 分 子 式 】C11H14BrN

【 分 子 量 】240.1429

【元素组成】C 55.02% H 5.88% Br 33.27% N 5.83%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XI)

Synthesis of Intermediate (VII): Acylation of p-chloroaniline (I) with dimethylmalonic acid (A) and SOCl2 gives (II), which is then cyclized to quinolinedione (III) by means of P2O5 in CH3SO3H. Reduction of the carbonyl groups of (III) with LiAlH4 in THF/Et2O in presence of AlCl3 provides tetrahydroquinoline (IV), which is further sulfonated with pyridine/SO3, yielding derivative (V). Removal of the chloro substituent of (V) by hydrogenation in basic conditions (in the presence of either NaHCO3/H2O or Et3N in MeOH) affords sulfonic acid (VI), which is converted to the sulfonyl chloride (VII) by means of ultrasound in acetonitrile or 1,3-dimethylimidazolidin-2-one (DMID) followed by treatment with POCl3 in pyridine. This conversion can also be achieved by treatment with PPh3 in dichloromethane and sulfuryl chloride. Alternatively, (V) can be converted into (VII) by a first sulfonation to yield (VIII) followed by removal of the chloro substituent in the same conditions described above. Intermediate (VI) can also be obtained as follows: Bromination of quinolinone (IX) with Br2 in CHCl3 yields derivative (X), which is then reduced with LiAlH4/AlCl3 in THF/Et2O to give tetrahydroquinoline (XI). (XI) is then converted into (XII) by sulfonation with DMF/sulfur trioxide complex. Finally, hydrogenation of (XII) over Pd/C in the presence of NaHCO3 allows removal of the bromo substituent, providing (VI).

1 Donovan, V.; Brundish, D.; Bull, A.; et al.; Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency. J Med Chem 1999, 42, 22, 4584.
2 Hoyle, W.; Howarth, G.A.; Brundish, D.E.; Kane, P.D.; Walker, C.V.; Hayler, J.; Fullerton, J.D.; Smith, G.P.; Wathey, W.B.; Le Grand, D.M.; Allen, M.C.; Herold, P. (Novartis AG); Trypsin and thrombin inhibitors. EP 0815103; JP 1999502219; WO 9629327 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 42999 2,2-dimethylmalonic acid 595-46-0 C5H8O4 详情 详情
(I) 12034 4-Chlorophenylamine; 4-Chloroaniline; p-Chloroaniline 106-47-8 C6H6ClN 详情 详情
(II) 43000 3-(4-chloroanilino)-2,2-dimethyl-3-oxopropionic acid C11H12ClNO3 详情 详情
(III) 43001 6-chloro-3,3-dimethyl-2,4(1H,3H)-quinolinedione C11H10ClNO2 详情 详情
(IV) 43002 3,3,6-trimethyl-1,2,3,4-tetrahydroquinoline C12H17N 详情 详情
(V) 43003 6-chloro-3,3-dimethyl-1,2,3,4-tetrahydro-8-quinolinesulfonic acid C11H14ClNO3S 详情 详情
(VI) 43004 3,3-dimethyl-1,2,3,4-tetrahydro-8-quinolinesulfonic acid C11H15NO3S 详情 详情
(VII) 43005 3,3-dimethyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl chloride C11H14ClNO2S 详情 详情
(VIII) 43006 6-chloro-3,3-dimethyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl chloride C11H13Cl2NO2S 详情 详情
(IX) 43007 3,3-dimethyl-3,4-dihydro-2(1H)-quinolinone C11H13NO 详情 详情
(X) 43008 6-bromo-3,3-dimethyl-3,4-dihydro-2(1H)-quinolinone C11H12BrNO 详情 详情
(XI) 43009 6-bromo-3,3-dimethyl-1,2,3,4-tetrahydroquinoline C11H14BrN 详情 详情
(XII) 43010 6-bromo-3,3-dimethyl-1,2,3,4-tetrahydro-8-quinolinesulfonic acid C11H14BrNO3S 详情 详情
Extended Information